London: Up to one in 10 women could benefit from anti-cancer treatments such as tamoxifen even before they show signs of the disease. But there are concerns the drug could have side effects, such as blood clots and, in some cases, womb cancer, according to an international panel of experts. The specialists call for a radical new approach to identifying and treating patients who are at risk, the journal Lancet Oncology reports.
Jack Cuzick from Queen Mary University of London, who led the study, said doctors should be authorised to prescribe tamoxifen as a preventive therapy in the UK, even though the drug can have serious side-effects. The report, which followed an international conference of 150 breast cancer specialists in London last year, also recommended widening the methods used to identify women who are at risk of developing the disease. IANS
Azam Khan calls Modi a Fascist
Don`t rush with the Lokpal :BJP
CBI questions Madhu Koda on Coalgate
Stop govt from appointing new Army chief: BJP to Election Commission